The short version
7 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 32% in a year, to $0.8314 per mL — and generics that get this cheap tend to get abandoned rather than defended. One of its named manufacturing plants, Somerset Therapeutics Private Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.